CT-guided microwave ablation for large inoperable pulmonary metastases from sarcoma: a case series
British Journal of Radiology · 01.09.2026 · 99 (1185) · 1910-1917
DOI: 10.1093/bjr/tqag088 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, online erschienen am 08.06.2026. Verfasst von Lin Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Minimally Invasive Interventional Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510000, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Sarcoma, Tomography, X-Ray Computed, Microwaves. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
This study aimed to retrospectively evaluate the feasibility, efficacy and safety of percutaneous computed tomography (CT)-guided microwave ablation (MWA) for the treatment of large inoperable pulmonary metastases from sarcoma.
Methods
The study was approved by the institutional review board, and informed consent was obtained from all patients. From January 1, 2011, to May 1, 2018, 15 patients with sarcoma (9 males and 6 females; median age 35 years) with 17 large inoperable pulmonary metastases from sarcoma (mean size, 7.6 ± 1.7 cm; range, 5.0-10.8 cm) received percutaneous CT-guided microwave ablation. The treatment efficacy, complications and overall survival were evaluated.
Results
The median follow-up was 24.6 months (range 1.6-65.8 months). Complete response was achieved in 4 tumors (23.5%), partial response in 11 tumors (64.7%), while 2 tumors (11.8%) demonstrated disease progression. The 1-, 2- and 3-year overall survival rates were 78.6%, 69.8% and 50.9%, respectively. The median overall survival time was 39 months (95% CI 18.2-59.8 months). Curative ablation was associated with significantly improved local progression-free survival compared with palliative ablation (median LPFS: not reached vs 17.09 months; HR 4.913, 95% CI: 1.039-23.24, P = .046). No treatment-related death occurred. Pneumothorax was the most common complication with an incidence of 20.8%(n = 5). The median hospital stay was 5 days.
Conclusion
CT-guided microwave ablation appears to be a safe and effective treatment for large inoperable pulmonary metastases from sarcoma. Advances in knowledge CT-guided MWA can be used as an alternative treatment for patients with large inoperable lung metastases from sarcoma with potential clinical benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Minimally Invasive Interventional Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510000, China.
- State Key Laboratory of Oncology in South China, Sun Yat-sen University, Guangzhou, 510000, China.
- Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, 510000, China.
ORCID-Profile: Weijun Fan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xie, L., Cao, F., Shen, L., Qi, H., Huang, T., Wu, Y., Chen, S., & Fan, W. (2026). CT-guided microwave ablation for large inoperable pulmonary metastases from sarcoma: a case series. British Journal of Radiology, 99(1185), 1910-1917. https://doi.org/10.1093/bjr/tqag088
Vancouver
Xie L, Cao F, Shen L, Qi H, Huang T, Wu Y, et al. CT-guided microwave ablation for large inoperable pulmonary metastases from sarcoma: a case series. British Journal of Radiology. 2026;99(1185):1910-1917. doi:10.1093/bjr/tqag088
BibTeX
@article{Xie2026,
author = {Xie, Lin and Cao, Fei and Shen, Lujun and Qi, Han and Huang, Tao and Wu, Ying and Chen, Shuanggang and Fan, Weijun},
title = {CT-guided microwave ablation for large inoperable pulmonary metastases from sarcoma: a case series},
journal = {British Journal of Radiology},
year = {2026},
volume = {99},
number = {1185},
pages = {1910--1917},
doi = {10.1093/bjr/tqag088}
}
EUVIMED